The "United Kingdom Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update" report has been added to offering.

The diabetes market in United Kingdom is expected to grow by 8.7% on annual basis to reach US$7.05 billion in 2025. The diabetes market in the country has experienced robust growth during 2020-2024, achieving a CAGR of 9.5%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 7.2% during 2025-2029. By the end of 2029, the diabetes market is projected to expand from its 2024 value of USD 6.48 billion to approximately USD 10.09 billion.

This report provides a detailed data-centric analysis of the diabetes industry in United Kingdom, covering market opportunities and analysis across a range of diagnosis and monitoring devices, therapeutics, domains. With over 50+ KPIs at the country level, this report provides a comprehensive understanding of diabetes market dynamics, market size and forecast, and market share statistics.

The competitive landscape is expected to evolve with increased consolidation and strategic alliances, especially as digital integration becomes a focal point. Enhanced competition is anticipated between firms focused on traditional devices and those prioritizing innovative digital solutions. Intensified competition will likely drive further innovation and refined product offerings, resulting in more targeted patient management strategies. Over the next 2-4 years, strategic collaborations and market consolidation are expected to solidify competitive positioning across the UK.

The UK diabetes devices and therapeutics market comprises a dynamic mix of multinational leaders and emerging local innovators. Recent strategic partnerships, mergers, and acquisitions are reshaping competitive dynamics, with an increasing emphasis on digital integration and regulatory alignment. In the coming years, heightened competition and strategic collaborations are expected to drive innovation and enhance patient management solutions across the UK diabetes care sector.

The UK diabetes devices and therapeutics market is being reshaped by increased CGM adoption, enhanced digital health integration, growth in connected therapeutic devices, and evolving regulatory frameworks. Over the next 2-4 years, these trends are projected to intensify, leading to improved patient management and fostering innovation within the diabetes care landscape.

• Others

• Type 1 Diabetes
• Type 2 Diabetes

• Online Pharmacies
• Hospital Pharmacies
• Retail Pharmacies

Diabetes Devices and Therapeutics Market Share by End User

• Hospitals
• Diabetes Clinics
• Homecare

Key Attributes:

For more information about this report visit https://www.researchandmarkets.com/r/j41hel

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250715346666/en/